Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond annotations by disclosing the parallel fan-out across sources, the USPTO soft-fail behavior, the meaning of sources_used/sources_failed, and the explicit statement that an empty fda_products section is expected for non-biologic companies. It even explains resolved:false returns for private companies with a notes line. This gives the agent strong behavioral expectations that annotations alone could not convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long, but dense with purpose-built information. It front-loads examples and the core directive, then uses a structured list for return fields and a clear statement about sources_used/failed. No sentence is filler; the length is justified because there is no output schema and this tool aggregates many distinct data sources. It could be tightened slightly, but it earns most of its length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (many fan-out sources, no output schema, only 2 params), the description is remarkably complete. It enumerates all return fields (cik, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI), explains edge cases (private companies, patent API sunset, empty fda_products), and covers input variants. An agent has everything needed to decide when and how to invoke it.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is already 100%, so the schema fully documents the two parameters. The description adds value by clarifying that type's enum values are interchangeable ('both are accepted and behave identically') and by giving concrete, varied examples of acceptable value formats (ticker, zero-padded CIK, name). It also explains name resolution via SEC EDGAR and the private-company failure mode, which the schema does not.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete query examples ('Tell me about X', 'research Acme', 'brief me on Tesla') and then states the exact function: 'full cross-source profile of a US public company in ONE parallel call.' It clearly distinguishes itself from chaining single-pack lookups and from siblings like resolve_entity or compare_entities by emphasizing the holistic, multi-source nature.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' providing clear conditions for use. It also explains valid input forms and the expected behavior for private companies. However, it does not explicitly contrast with sibling tools like compare_entities or resolve_entity, leaving some routing decisions to the agent.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tool families have unclear boundaries: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, suggest_questions and discover_tools are near-duplicates, and ai_visibility_check is a subset of scan_competitor_ai_presence. The five polymarket_* tools are heavily overlapping in purpose and rely on long descriptions to distinguish them, which an agent must read carefully to avoid misselection.

Naming Consistency3/5

All names are lowercase snake_case and there are helpful prefixes (polymarket_*, ask_pipeworx_*, pipeworx_*), but the verb/noun ordering is inconsistent: verb-first names (generate_llms_txt, resolve_entity, scan_dependency) sit alongside noun-first names (bet_research, entity_profile, recent_changes) and bare verbs (forget, recall, remember). Sub-families are internally consistent, but the set as a whole follows no single convention.

Tool Count2/5

32 tools is over the 'too many' threshold, and the scope is a grab-bag rather than a focused server: data research, prediction-market analysis, npm dependency checks, llms.txt generation, memory utilities, subscriptions, and exactly one tarot tool. The server is named 'Tarot Draw' yet 31 of 32 tools serve a completely different purpose, making the count wildly mismatched to the apparent identity.

Completeness2/5

For the inferred Pipeworx data/prediction-market domain the coverage is genuinely deep — ask/grounded/deep research, entity resolution, profiles, comparisons, validation, subscriptions, alerts, edge tracking, and arbitrage all exist. But for the stated purpose ('Tarot Draw'), the surface is one draw tool with no deck details, spreads, reading history, or reversal support, and the data tools' domain is so diffuse that an agent cannot rely on the set forming a coherent workflow.